All Stories

  1. Detection of antibodies against the African parasite Trypanosoma brucei using synthetic glycosylphosphatidylinositol oligosaccharide fragments
  2. Quantitative assessment of the 3D pore space and microglobule clustering network to understand chromatographic transport phenomena in polymeric monolithic columns
  3. Infection history imprints prolonged changes to the epigenome, transcriptome and function of Kupffer cells
  4. Beyond the VSG layer: Exploring the role of intrinsic disorder in the invariant surface glycoproteins of African trypanosomes
  5. Q586B2 is a crucial virulence factor during the early stages of Trypanosoma brucei infection that is conserved amongst trypanosomatids
  6. Immunology of African Trypanosomiasis
  7. Trypanosomiasis
  8. Lipocalin-2: A Nurturer of Tumor Progression and a Novel Candidate for Targeted Cancer Therapy
  9. A few good reasons to use nanobodies for cancer treatment
  10. Hallmarks of Cancer Affected by the MIF Cytokine Family
  11. Differential plasticity and fate of brain-resident and recruited macrophages during the onset and resolution of neuroinflammation
  12. The Role of MIF and IL-10 as Molecular Yin-Yang in the Modulation of the Host Immune Microenvironment During Infections: African Trypanosome Infections as a Paradigm
  13. Detrimental Effect ofTrypanosoma brucei bruceiInfection on Memory B Cells and Host Ability to Recall Protective B-cell Responses
  14. Targeting the tsetse-trypanosome interplay using genetically engineered Sodalis glossinidius
  15. Macrophages are metabolically heterogeneous within the tumor microenvironment
  16. The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide Therapy
  17. Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation
  18. Immunogenicity Risk Profile of Nanobodies
  19. A Critical Blimp-1-Dependent IL-10 Regulatory Pathway in T Cells Protects From a Lethal Pro-inflammatory Cytokine Storm During Acute Experimental Trypanosoma brucei Infection
  20. Dehydrin ERD14 activates glutathione transferase Phi9 in Arabidopsis thaliana under osmotic stress
  21. Development of a recombinase polymerase amplification lateral flow assay for the detection of active Trypanosoma evansi infections
  22. A New Family of Diverse Skin Peptides from the Microhylid Frog Genus Phrynomantis
  23. Hepatocyte-derived IL-10 plays a crucial role in attenuating pathogenicity during the chronic phase of T. congolense infection
  24. Identification of Nanobodies against the Acute Myeloid Leukemia Marker CD33
  25. The Trypanosomal Transferrin Receptor of Trypanosoma Brucei—A Review
  26. Neutrophils enhance early Trypanosoma brucei infection onset
  27. Novel half-life extended anti-MIF nanobodies protect against endotoxic shock
  28. The anuran skin peptide bradykinin mediates its own absorption across epithelial barriers of the digestive tract
  29. African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System
  30. MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset
  31. Nanobodies As Tools to Understand, Diagnose, and Treat African Trypanosomiasis
  32. Reprint of: The non-mammalian MIF superfamily
  33. African Trypanosomes Undermine Humoral Responses and Vaccine Development: Link with Inflammatory Responses?
  34. The non-mammalian MIF superfamily
  35. Early Immunological Responses Upon Tsetse Fly–Mediated Trypanosome Inoculation
  36. List of Contributors
  37. MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis
  38. Immune Evasion Strategies of Trypanosoma brucei within the Mammalian Host: Progression to Pathogenicity
  39. Molecular Imaging with Kupffer Cell-Targeting Nanobodies for Diagnosis and Prognosis in Mouse Models of Liver Pathogenesis
  40. An Anti-proteome Nanobody Library Approach Yields a Specific Immunoassay for Trypanosoma congolense Diagnosis Targeting Glycosomal Aldolase
  41. The Possible Role of Staphylococcus epidermidis LPxTG Surface Protein SesC in Biofilm Formation
  42. M-CSF and GM-CSF Receptor Signaling Differentially Regulate Monocyte Maturation and Macrophage Polarization in the Tumor Microenvironment
  43. E-cadherin expression in macrophages dampens their inflammatory responsiveness in vitro, but does not modulate M2-regulated pathologies in vivo
  44. NK-, NKT- and CD8-Derived IFNγ Drives Myeloid Cell Activation and Erythrophagocytosis, Resulting in Trypanosomosis-Associated Acute Anemia
  45. Macrophage dynamics are regulated by local macrophage proliferation and monocyte recruitment in injured pancreas
  46. Development of a pHrodo-Based Assay for the Assessment of In Vitro and In Vivo Erythrophagocytosis during Experimental Trypanosomosis
  47. Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm
  48. Murine Liver Myeloid Cell Isolation Protocol
  49. Iron Homeostasis andTrypanosoma bruceiAssociated Immunopathogenicity Development: A Battle/Quest for Iron
  50. Generation of a Nanobody Targeting the Paraflagellar Rod Protein of Trypanosomes
  51. MIF Contributes to Trypanosoma brucei Associated Immunopathogenicity Development
  52. Antibody-mediated control ofTrypanosoma vivaxinfection fails in the absence of tumour necrosis factor
  53. Presence and regulation of insulin-regulated aminopeptidase in mouse macrophages
  54. Antibacterial activities of coagulase-negative staphylococci from bovine teat apex skin and their inhibitory effect on mastitis-related pathogens
  55. Low Structural Variation in the Host-Defense Peptide Repertoire of the Dwarf Clawed Frog Hymenochirus boettgeri (Pipidae)
  56. African Trypanosomiasis as Paradigm for Involvement of the Mononuclear Phagocyte System in Pathogenicity During Parasite Infection
  57. A Trypanosoma brucei Kinesin Heavy Chain Promotes Parasite Growth by Triggering Host Arginase Activity
  58. Origin and Functional Diversification of an Amphibian Defense Peptide Arsenal
  59. Characterization of central macrophages in Anemia of Inflammation (AI): African trypanosomiasis as a model system
  60. Correction: Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
  61. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism
  62. Affinity Is an Important Determinant of the Anti-Trypanosome Activity of Nanobodies
  63. Tsetse Salivary Gland Proteins 1 and 2 Are High Affinity Nucleic Acid Binding Proteins with Residual Nuclease Activity
  64. Vaccination with SesC Decreases Staphylococcus epidermidis Biofilm Formation
  65. Using microdialysis to analyse the passage of monovalent nanobodies through the blood–brain barrier
  66. Expression and extracellular release of a functional anti-trypanosome Nanobody® in Sodalis glossinidius, a bacterial symbiont of the tsetse fly
  67. Similar inflammatory DC maturation signatures induced by TNF or Trypanosoma brucei antigens instruct default Th2-cell responses
  68. IL-10 limits production of pathogenic TNF by M1 myeloid cells through induction of nuclear NF-κB p50 member inTrypanosoma congolenseinfection-resistant C57BL/6 mice
  69. High Affinity Nanobodies against the Trypanosome brucei VSG Are Potent Trypanolytic Agents that Block Endocytosis
  70. Lack of galectin-3 alleviates trypanosomiasis-associated anemia of inflammation
  71. Tip-DC Development during Parasitic Infection Is Regulated by IL-10 and Requires CCL2/CCR2, IFN-γ and MyD88 Signaling
  72. Current status of vaccination against African trypanosomiasis
  73. Scrutinizing the mechanisms underlying the induction of anemia of inflammation through GPI-mediated modulation of macrophage activation in a model of African trypanosomiasis
  74. The Central Role of Macrophages in Trypanosomiasis-Associated Anemia:Rationale for Therapeutical Approaches
  75. Identification of a Parasitic Immunomodulatory Protein Triggering the Development of Suppressive M1 Macrophages during African Trypanosomiasis
  76. Differentiation, activation and function of CD11b+Ly6C+ TNF/iNOS-producing dendritic cells during parasitic infection
  77. Understanding the role of monocytic cells in liver inflammation using parasite infection as a model
  78. Inhibition of Staphylococcus epidermidis Biofilm Formation by Rabbit Polyclonal Antibodies against the SesC Protein
  79. Liver X receptors contribute to the protective immune response against Mycobacterium tuberculosis in mice
  80. Camelid immunoglobulins and nanobody technology
  81. Role of iron homeostasis in trypanosomiasis-associated anemia
  82. Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens
  83. A Glycosylphosphatidylinositol-Based Treatment Alleviates Trypanosomiasis-Associated Immunopathology
  84. African trypanosomosis: From immune escape and immunopathology to immune intervention
  85. Traitement expérimental de la trypanosomiase africaine par le facteur trypanolytique humain combiné à un nanocorps
  86. Tsetse Fly Saliva Accelerates the Onset of Trypanosoma brucei Infection in a Mouse Model Associated with a Reduced Host Inflammatory Response
  87. Evidence for proteins involved in prophenoloxidase cascade Eisenia fetida earthworms
  88. Experimental therapy of African trypanosomiasis with a nanobody-conjugated human trypanolytic factor
  89. The Induction of a Type 1 Immune Response following a Trypanosoma brucei Infection Is MyD88 Dependent
  90. Antigen Binding and Solubility Effects upon the Veneering of a Camel VHH in Framework-2 to Mimic a VH
  91. P75 Tumor Necrosis Factor–Receptor Shedding Occurs as a Protective Host Response during African Trypanosomiasis
  92. Efficient Targeting of Conserved Cryptic Epitopes of Infectious Agents by Single Domain Antibodies
  93. VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology
  94. Control of Experimental Trypanosoma brucei Infections Occurs Independently of Lymphotoxin-α Induction
  95. Bacterial Lipoprotein-Based Vaccines Induce Tumor Necrosis Factor-Dependent Type 1 Protective Immunity against Leishmania major
  96. Distinct Carbohydrate Recognition Domains of an Invertebrate Defense Molecule Recognize Gram-negative and Gram-positive Bacteria
  97. A Conserved Flagellar Pocket Exposed High Mannose Moiety Is Used by African Trypanosomes as a Host Cytokine Binding Molecule
  98. Attenuation ofTrypanosoma bruceiIs Associated with Reduced Immunosuppression and Concomitant Production of Th2 Lymphokines
  99. Comparative Analysis of Antibody Responses against HSP60, Invariant Surface Glycoprotein 70, and Variant Surface Glycoprotein Reveals a Complex Antigen-Specific Pattern of Immunoglobulin Isotype Switching during Infection byTrypanosoma brucei
  100. Detection of clinically relevant antibodies pretransplant and posttransplant with PRA-STAT